Asclera® (polidocanol) Injection

Distributed by Merz North America
Merz North America at 1-866-862-1211
FDA at 1-800-FDA-1088

Indications

Asclera is indicated to sclerose uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity. Asclera® has not been studied in varicose veins more than 3 mm in diameter.

Contraindications

Asclera® (polidocanol) Injection is contraindicated for patients with known allergy (anaphylaxis) to polidocanol and patients with acute vein and blood clotting diseases.

Before & After
Photos

RESULTS AT 26 WEEKS AFTER LAST TREATMENT
Before Asclera<sup>®</sup> After Asclera<sup>®</sup>
Before After

Uncomplicated reticular veins treatment* 1 to 3 mm

*Individual results may vary depending on varicose vein severity, disease progression, skin tone, and number of treatments.

Photos: patients from EASI study